FDA Recalls 13,500 Chlorthalidone Bottles Over Dissolution Failures
The FDA has issued a Class II recall for 13,567 bottles of chlorthalidone 25mg tablets manufactured by Inventia Healthcare Limited. The recall, initially issued on September 3 and upgraded on September 17, stems from the medication failing dissolution specifications, which may prevent the drug from releasing its active ingredient properly. This is the second recall for this specific medication in three months, following a similar issue with Rising Pharma Holdings in June. Chlorthalidone is a diuretic used to treat high blood pressure and fluid retention. Patients are advised to stop using the affected product and consult their healthcare provider for an alternative.